Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DataMEDS AIMEDS -3.35% Gross Margin % is 10.90% as of Mar. 2026, which is 12% above its 10-year median of 9.75. The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, DataMEDS AI ranks worse than 100% on this metric.
The historical rank and industry rank for DataMEDS AI's Gross Margin % or its related term are showing as below:
MEDS'
s Gross Margin % Range Over the Past 10 Years
Min: -49.51 Med: 9.75 Max: 17.54
Current: -49.51
During the past 4 years, the highestGross Margin % of DataMEDS AI was 17.54%. The lowest was -49.51%. And the median was 9.75%.
MEDS's Gross Margin % is ranked worse than 100% of 118
companies
in the Medical Distribution industry
Industry Median: 14.9
vs MEDS: -49.51
DataMEDS AI had a gross margin of 10.90% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for DataMEDS AI was 0.00% per year.
DataMEDS AI (NAS:MEDS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DataMEDS AI had a gross margin of 10.90% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
DataMEDS AI Gross Margin % Related Terms
DataMEDS AI Gross Margin % Historical Data
* Premium members only.
The historical data trend for DataMEDS AI's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDS vs HEWA, BLMH, PMHS: Gross Margin % Comparison
For the Medical Distribution subindustry, DataMEDS AI's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DataMEDS AI Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, DataMEDS AI's Gross Margin % distribution charts can be found below:
* The bar in red indicates where DataMEDS AI's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DataMEDS AI (MEDS) has a Gross Margin % of 10.90% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on DataMEDS AI and its competitors. This is 12% above median its historical median of 9.75. According to the industry distribution chart, DataMEDS AI ranks #118 out of 118 companies in the Medical Distribution industry.
Is DataMEDS AI's Gross Margin % too high?
DataMEDS AI's current Gross Margin % of 10.90% is 12% above median its 10-year median of 9.75. The Medical Distribution industry median Gross Margin % is 14.90. DataMEDS AI's value of 10.90% is 26.8% below this industry median. Based on the distribution chart, DataMEDS AI ranks #118 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does DataMEDS AI's Gross Margin % compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #118 out of 118 companies for Gross Margin %. This places DataMEDS AI in the lower half of its industry. The industry median Gross Margin % is 14.90. DataMEDS AI's value of 10.90% is 26.8% below this benchmark. While the company's 10-year median is 9.75 vs. the industry median of 14.90, DataMEDS AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DataMEDS AI's current Gross Margin % of 10.90% is 26.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on DataMEDS AI and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DataMEDS AI's current Gross Margin % is 10.90%, which is 12% above median its own 10-year median of 9.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Gross Margin % of 10.90%. The current Gross Margin % is 10.90%, which is 12% above median its 10-year median of 9.75 and 26.8% below the Medical Distribution industry median of 14.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Gross Margin % is 10.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDS has been successfully added to your 
